Zevra Therapeutics, Inc.ZVRANASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
0.70%
↓ 98% below average
Average (39q)
33.71%
Historical baseline
Range
High:412.13%
Low:-88.00%
Volatility
1483.7%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 0.70% |
| Q2 2025 | 26.86% |
| Q1 2025 | 69.40% |
| Q4 2024 | 225.93% |
| Q3 2024 | -16.95% |
| Q2 2024 | 29.90% |
| Q1 2024 | -74.09% |
| Q4 2023 | 356.55% |
| Q3 2023 | -65.82% |
| Q2 2023 | 166.69% |
| Q1 2023 | 36.96% |
| Q4 2022 | -19.31% |
| Q3 2022 | 121.08% |
| Q2 2022 | -67.21% |
| Q1 2022 | 53.56% |
| Q4 2021 | 31.40% |
| Q3 2021 | -83.61% |
| Q2 2021 | -1.08% |
| Q1 2021 | 412.13% |
| Q4 2020 | 22.91% |
| Q3 2020 | -72.13% |
| Q2 2020 | 230.68% |
| Q1 2020 | 51.82% |
| Q4 2019 | -88.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |